GIACOPUZZI, Simone
 Distribuzione geografica
Continente #
EU - Europa 2.569
NA - Nord America 2.451
AS - Asia 1.468
SA - Sud America 47
AF - Africa 43
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.592
Nazione #
US - Stati Uniti d'America 2.435
GB - Regno Unito 832
CN - Cina 821
SG - Singapore 434
IT - Italia 385
RU - Federazione Russa 289
IE - Irlanda 247
SE - Svezia 240
FR - Francia 183
DE - Germania 143
FI - Finlandia 124
KR - Corea 40
UA - Ucraina 40
VN - Vietnam 40
JP - Giappone 39
TG - Togo 32
BR - Brasile 31
TR - Turchia 28
NL - Olanda 21
HK - Hong Kong 14
CA - Canada 13
AT - Austria 12
BE - Belgio 10
AU - Australia 9
ID - Indonesia 9
NO - Norvegia 9
ES - Italia 6
IR - Iran 6
EU - Europa 5
PT - Portogallo 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IL - Israele 4
IN - India 4
LT - Lituania 4
AR - Argentina 3
CO - Colombia 3
EG - Egitto 3
KG - Kirghizistan 3
LK - Sri Lanka 3
PK - Pakistan 3
SI - Slovenia 3
UY - Uruguay 3
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
PE - Perù 2
SC - Seychelles 2
TW - Taiwan 2
UG - Uganda 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
IQ - Iraq 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
OM - Oman 1
PH - Filippine 1
PL - Polonia 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 6.592
Città #
Southend 796
Chandler 486
Singapore 339
Jacksonville 264
Dublin 247
Woodbridge 184
Beijing 159
Ashburn 156
Ann Arbor 122
New York 122
Verona 111
Jinan 75
Lawrence 73
Princeton 73
Wilmington 70
Redmond 56
Nanjing 52
Helsinki 51
Shenyang 46
Houston 44
Hebei 40
Seoul 37
Tokyo 37
Milan 33
Lomé 32
Sindelfingen 30
Changsha 29
Los Angeles 25
Zhengzhou 25
Dong Ket 24
Haikou 22
Tianjin 22
Seattle 21
Nanchang 19
Guangzhou 18
Hangzhou 18
Washington 17
Santa Clara 16
Taizhou 16
Amsterdam 15
Dallas 15
Jiaxing 15
Ningbo 15
Moscow 14
Tombolo 14
Redwood City 13
Rome 13
Taiyuan 13
Hong Kong 12
Boardman 11
Brussels 10
Dongguan 10
Lappeenranta 10
Vienna 10
Jakarta 9
Fuzhou 8
Norwalk 8
Padova 8
Fredrikstad 7
San Francisco 7
Storo 7
Toronto 7
Bologna 6
Dearborn 6
Erba 6
Frankfurt am Main 6
Renton 6
Chicago 5
Düsseldorf 5
Florence 5
Lancaster 5
Lanzhou 5
San Diego 5
Sant'Ambrogio di Valpolicella 5
Adelaide 4
Ankara 4
Cagliari 4
Kent 4
Ottawa 4
Piemonte 4
Shanghai 4
Belo Horizonte 3
Bishkek 3
Brescia 3
Bussolengo 3
Cairo 3
Cambridge 3
Colombo 3
Detroit 3
Falls Church 3
Grosuplje 3
Karachi 3
Montevideo 3
Munich 3
Nürnberg 3
Pompei 3
San Giovanni Lupatoto 3
Santiago 3
São Paulo 3
Trento 3
Totale 4.408
Nome #
An FGFR3 autocrine loop sustains acquired resistance to trastuzumab in gastric cancer patients 212
Extranodal extension of lymph node metastasis is a marker of poor prognosis in oesophageal cancer: a systematic review with meta-analysis 190
Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer. 129
[Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal junction]. 122
ypN0: Does It Matter How You Get There? Nodal Downstaging in Esophageal Cancer 121
Adenocarcinoma of the esophagogastric junction 115
Surgical treatment of gastric cancer with coexistent abdominal aortic aneurysm. Personal experience and literature review 111
The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015 111
Neoadjuvant Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer in a Single High-Volume Center. 101
TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients 101
Evaluation of Siewert classification in gastro-esophageal junction adenocarcinoma: What is the role of endoscopic ultrasonography? 100
Enhanced recovery after surgery protocol in patients undergoing esophagectomy for cancer: a single center experience 97
Changing clinical and pathological features of gastric cancer over time. 96
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new? 96
Response to induction therapy in oesophageal and cardia carcinoma using Mandard tumour regression grade or size of residual foci 95
Thoracic Aortic Pseudoaneurysm after Esophageal Perforation and Mediastinitis Caused by Accidental Ingestion of a Mutton Bone: A Case Report on Staged Endoscopic and Endovascular Treatments 92
Siewert III esophagogastric junction adenocarcinoma: does TNM 8th save us? 91
Western strategy for EGJ carcinoma 90
The amount of cells with Signet Ring Cell morphology has a prognostic impact in poorly cohesive gastric carcinoma 90
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy 88
Super-extended (D3) lymphadenectomy in advanced gastric cancer . 86
Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study 85
Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion. 85
Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre 85
Proximal Gastrectomy: Technical Notes 83
Lymphadenectomy: how to do it? 82
Preliminary results of neoadjuvant treatment of adenocarcinoma of the gastro-esophageal. 79
Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer 79
Acute bleeding obstruction pancreatitis after Roux-en-Y anastomosis in total gastrectomy: a single center experience 79
L’ espressione di BIRC3 come predittore di resistenza alla chemioradioterapia neoadiuvante nell’adenocarcinoma del cardias e nel carcinoma squamoso dell’esofago 78
Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer 77
Feasibility and safety of an enhanced recovery protocol (ERP) for upper GI surgery in elderly patients (≥ 75 years) in a high-volume surgical center 77
Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery 76
Gastric stump cancer after distal gastrectomy for benign disease: clinicopathological features and surgical outcomes. 76
Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System. Ann Surg Oncol. 75
Long term results of ajuvant treatment in epidermoid carcinoma of the thoracic esophagus 75
Complications after gastrectomy for cancer: Italian perspective 75
Multicenter Study of Presentation, Management, and Postoperative and Long-Term Outcomes of Septegenerians and Octogenerians Undergoing Gastrectomy for Gastric Cancer 75
Tumor Site and Perigastric Nodal Status are the Most Important Predictors of Para-Aortic Nodal Involvement in Advanced Gastric Cancer 74
Is there any role for super-extended limphadenectomy in advanced gastric cancer? results of an observational study from a western high volume center 74
Utility of Abdominal Drain in Gastrectomy (ADiGe) Trial: study protocol for a multicenter non-inferiority randomized trial 74
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 73
Severe necrotic and septic pancreatitis. Indications to endoscopic surgical and nutritional therapy 71
Limited Usefulness of 18F-FDG PET/CT in Predicting Tumor Regression After Preoperative Chemotherapy for Noncardia Gastric Cancer: The Italian Research Group for Gastric Cancer (GIRCG) Experience 71
Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. 70
Treatment of esophago-gastric junction adenocarcinoma 70
ASO Author Reflections: Recurrence After Pathological Complete Response in Esophageal Cancer: Analysis of Risk Factors for this Unexpected Event 70
Incidence and Grading of Complications After Gastrectomy for Cancer Using the GASTRODATA Registry: A European Retrospective Observational Study 70
External Validation of a Score Predictive of Recurrence after Radical Surgery for Non-Cardia Gastric Cancer: Results of a Follow-Up Study 68
Textbook outcome following oesophagectomy for cancer: international cohort study 66
Indexes of surgical quality in gastric cancer surgery: experience of an Italian network 66
Laparoscopic transhiatal suture and gastric valve as a safe and feasible treatment for Boerhaave's syndrome: an Italian single center case series study 66
Gastric conduit perforation after Ivor Lewis esophagectomy successfully treated with endoscopic vacuum therapy (E-VAC): a case report 66
Perianastomotic drainage in Ivor-Lewis esophagectomy, does habit affect utility? An 11-year single-center experience 65
Risultati preliminari del trattamento neoadiuvante dell’adenocarcinoma del giunto esofago-gastrico. 64
Tailored treatment for signet ring cell gastric cancer 64
Esophageal surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it 63
Pediatric Palliative Care: Historical Origins and a Glimpse into Ethical Issues 62
Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives 62
Preliminary Experience with Prophylactic Thoracic Endovascular Aortic Repair in Patients Affected by Advanced Esophageal Cancer 62
International consensus on a complications list after gastrectomy for cancer 62
Effect of Pyloroplasty on Gastric Conduit Emptying and Patients' Quality of Life After Ivor Lewis Esophagectomy 61
Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 60
Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer 58
A national survey on the current status of minimally invasive gastric practice on behalf of GIRCG 57
Effectiveness of endoscopic vacuum therapy as rescue treatment in refractory leaks after gastro-esophageal surgery 57
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy 57
Adenocarcinoma of the esophagogastric junction; going up or down? 55
Follow-up after gastrectomy for cancer. An appraisal of the Italian Research Group for Gastric Cancer 53
Turning left or right? A comparative analysis in adenocarcinomas of the esophagogastric junction according to the seventh AJCC TNM classification for cancers of the esophagus and stomach: experience in a Chinese single institution 50
Recurrence in node-negative advanced gastric cancer: Novel findings from an in-depth pathological analysis of prognostic factors from a multicentric series 49
Cutoff values of major surgical complications rates after gastrectomy 49
Long-Term Outcomes of Induction Chemotherapy Followed by Chemo-Radiotherapy as Intensive Neoadjuvant Protocol in Patients with Esophageal Cancer 48
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma 47
Current practice on the use of prophylactic drain after gastrectomy in Italy: the Abdominal Drain in Gastrectomy (ADiGe) survey 44
Impact of COVID-19 outbreak on esophageal cancer surgery in Northern Italy: lessons learned from a multicentric snapshot 44
Outcomes after Surgical Treatment of Oesophagogastric Cancer with Synchronous Liver Metastases: A Multicentre Retrospective Cohort Study 40
Comparison of outcomes of multiple platforms for assisted robotic-prostatectomy: rationale and design 39
Comparison of short-term outcomes from the International Oesophago-Gastric Anastomosis Audit (OGAA), the Esophagectomy Complications Consensus Group (ECCG), and the Dutch Upper Gastrointestinal Cancer Audit (DUCA) 38
Treatment of EGJ Cancer within or outside clinical trials: Does the setting matter? A monocentric prospective observational study 35
Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study 31
Is a robot surgeon with AI the ideal surgeon? A philosophical analysis 28
Robotic versus open Ivor-Lewis esophagectomy: A more accurate lymph node dissection without burdening the leak rate 28
Active surveillance for clinical complete responders after chemoradiotherapy for oesophageal squamous cell carcinoma 28
Long-Term Results with Surgery Alone and Multimodal Treatments 27
RAMIE: tradition drives innovation-feasibility of a robotic-assisted intra-thoracic anastomosis 27
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 25
The "Weekday Effect" on Enhanced Recovery after Surgery Protocol for Gastrectomy 24
MULTICENTER STUDY ON THE INCIDENCE AND TREATMENT OF MEDIASTINAL LEAKS AFTER ESOPHAGECTOMY (MUMELE 2) 24
The green indocyanine: the meaning of one tracer for the intra-peri operative imaging and vascular evaluation in the reconstructive surgery of head and neck: an experimental multidisciplinary study 23
Open versus laparoscopic gastrectomy for advanced gastric cancer: a propensity score matching analysis of survival in a western population-on behalf of the Italian Research Group for Gastric Cancer 22
Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study 22
Morbid-Mortality and Treatment of Complications 22
Does Pathological Stage and Nodal Involvement Influence Long Term Oncological Outcomes after CROSS Regimen for Adenocarcinoma of the Esophagogastric Junction? A Multicenter Retrospective Analysis 20
Indocyanine green fluorescence-guided intraoperative detection of peritoneal carcinomatosis: systematic review 20
Clinical outcomes of patients with complicated post-operative course after gastrectomy for cancer: a GIRCG study using the GASTRODATA registry 18
Prosthetic voice rehabilitation after laryngoesophagectomy: surgical and functional outcomes 18
ASO Visual Abstract: Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM) 17
Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab 16
The influence of anastomotic techniques on postoperative anastomotic complications: Results of the Oesophago-Gastric Anastomosis Audit 14
Totale 6.623
Categoria #
all - tutte 30.181
article - articoli 28.382
book - libri 316
conference - conferenze 304
curatela - curatele 0
other - altro 257
patent - brevetti 0
selected - selezionate 0
volume - volumi 922
Totale 60.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020399 0 0 0 0 0 0 140 47 17 62 53 80
2020/2021742 93 106 26 93 78 75 32 27 42 60 69 41
2021/2022549 28 156 1 48 27 25 8 40 15 20 31 150
2022/20231.459 82 152 133 217 115 373 5 105 179 17 32 49
2023/20241.010 25 69 70 108 90 203 48 60 24 69 189 55
2024/20251.168 122 143 140 414 141 154 54 0 0 0 0 0
Totale 6.748